|
|
Tackling Therapeutic Inertia: Utilizing Continuous Glucose Monitoring for Diabetes Prevention and Optimal Management
|
|
Facebook
LinkedIn
E-Mail
|
(2392)
Category: Primary Care, [Free CE for AANP Members], 2025 National Conference, Adult-Gerontology, Cert Exam Domain - Assessment, Cert Exam Domain - Evaluation, Cert Exam Domain - Planning, Durable Medical Equipment, Endocrine, Health Promotion, Individual Across the Lifespan, NP Students, Optum Recommended Education, Preventable Disease (show less)
|
Released: 06/27/2025
Expires: 07/31/2026 (subject to change)
- CE for this activity will not be available after this date.
 | This activity includes closed captioning. |
| Delivery Note: The content for this activity was presented during the 2025 AANP National Conference. If you already completed the content of this activity (session ID 25.4.067) while attending the live or virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies. |
Overview
This program explores the expanding role of nurse practitioners in utilizing continuous glucose monitors (CGMs) for diabetes prevention and management in the primary care setting. Participants will gain insight into the clinical utility, evidence base, and practical application of CGM technology, including its benefits in both insulin-treated and non-insulin-treated patients as well as individuals without diabetes. Emphasis is placed on shared decision-making, addressing disparities in CGM access, and translating glucose data into meaningful therapeutic and lifestyle interventions.
Objectives
- Describe the fundamental clinical utility of continuous glucose monitoring (CGM) in the active treatment of type 1 diabetes (T1D) and type 2 diabetes (T2D), as well as in diabetes prevention.
- Identify the expanding frontline responsibility of primary care clinicians in the initiation, interpretation, and utilization of CGM, focusing on the role of the nurse practitioner (NP).
- Evaluate the clinical trial evidentiary base and recent regulatory updates for CGM systems, highlighting their increasing role in non-insulin dependent T2D and in people without diabetes.
- Implement impactful therapeutic and/or lifestyle modifications based on CGM data, with emphasis on the vital importance of active shared decision-making in primary care.
Speakers
Kathryn Evans-Kreider, DNP, FNP-BC, BC-ADM, FAANP
Debbie Hinnen, APN, BC-ADM, FAAN, FADCES
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.
The speakers have the following disclosures: - Deborah Hinnen
- On the Speakers’ Bureau for Novo Nordisk, Lilly, Sanofi, and Therasense Bio on the topic of diabetes.
- Consultant for Novo Nordisk on the topic of diabetes.
- Kathryn Evans-Kreider
All Planners involved in this activity have no relevant financial relationships to disclose.
This activity is supported by an independent medical educational grant from Abbott Diabetes.
Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions- Read this activity description, including objectives and disclosures.
- Take pretest.
- Complete the educational content:
- Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Click on the Additional Resources button to review all additional materials provided (slide handouts and any other downloadable resources).
- After completing all content, click on the blue Next Steps button:
- Take post-test.
- Submit the evaluation to receive full AANP CE/Rx credit.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
| 1.2 Contact Hour(s) of CE |
|
|
|
Adding Registration, Please wait...
